针对免疫细胞的小分子:癌症治疗的新方法
Shilpi Singh1, Debashis Barik2, Ananta Prasad Arukha1
1Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA.
Biomedicines
|October 28, 2023
概括
小分子可以在瘤微环境 (TME) 中准新的与生相似的T (ILT) 细胞和混合细胞 (HC). 这种方法通过克服耐药性和改善抗瘤反应来增强癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的免疫疗法面临着诸如耐药性和毒性等挑战.
- 瘤微环境 (TME) 极大地影响了癌症的进展.
- 新型细胞种群,包括与生俱来的类似T (ILT) 细胞和混合细胞 (HCs),表现出侵略性的促进瘤的特征.
研究的目的:
- 探索小分子在TME内调节免疫细胞的潜力.
- 研究针对ILT细胞和HCs等耐药细胞群的策略.
- 通过结合小分子调节器来增强现有的癌症免疫疗法.
主要方法:
- 审查最近关于ILT细胞和HCs的发现.
- 对针对TME组件的小分子免疫调节剂的分析.
- 探索小分子和免疫治疗之间的协同效应.
主要成果:
- ILT细胞和HC细胞表现出增强的增殖,迁移和耐药性.
- 小分子提供了一种有希望的策略,以准这些耐药细胞群.
- 组合疗法显示出具有协同抗瘤活性的潜力.
结论:
- 用小分子准ILT细胞和HCs代表了一个新的治疗途径.
- 小分子调节器可以克服免疫疗法耐药性并降低毒性.
- 这种方法可以通过微调TME内的免疫反应来彻底改变癌症治疗.
关键词:
混合细胞 混合细胞 混合细胞免疫疗法 免疫疗法一种与生俱来的类似细胞.杀手天生的类似T细胞.来自骨髓细胞的抑制细胞.监管T细胞的监管性T细胞它们是小分子.组织内存T细胞 组织内存T细胞瘤微环境是一个微环境.更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
01:27Cytotoxic T Cells-mediated Immune Response
933
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
933
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K